BioXcel Therapeutics (BTAI) Other Working Capital Changes (2021 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Other Working Capital Changes of -$65000.0 for Q1 2026, up 27.78% year-over-year from -$50869.6 in Q1 2025, and up 31.58% quarter-over-quarter from -$95000.0 in Q4 2025.
BioXcel Therapeutics (BTAI) Other Working Capital Changes (2021 - 2026) Analysis & Trends
BioXcel Therapeutics' Other Working Capital Changes history runs 6 years deep, the most recent figure standing at -$65000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 27.78% year-over-year to -$65000.0; the TTM figure through Mar 2026 stood at -$349000.0 (up 1.13% YoY), while the FY2025 annual figure was -$374000.0, down 8.09% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$65000.0, up from -$95000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $8.3 million in Q4 2025, with the low at -$2.3 million in Q3 2023.
- The 5-year median for Other Working Capital Changes is $459000.0 (2024), against an average of $710823.5.
- The sharpest annual moves came in 2024 and 2026: Other Working Capital Changes slipped 10.13% in 2024, then gained 27.78% in 2026.
- BioXcel Therapeutics' Other Working Capital Changes stood at -$75000.0 in 2022, then decreased by 9.33% to -$82000.0 in 2023, then decreased by 7.32% to -$88000.0 in 2024, then fell by 7.95% to -$95000.0 in 2025, then soared by 31.58% to -$65000.0 in 2026.
- Business Quant data shows BTAI's Other Working Capital Changes at -$65000.0 in Q1 2026, -$95000.0 in Q4 2025, and -$96000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | BioXcel Therapeutics | 24.29 Mn | 24.29 Mn | 160,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65,000.00 |
| Mar 31, 2026 | -65,000.00 |
| Mar 31, 2026 | -65,000.00 |
| Dec 31, 2025 | -95,000.00 |
| Dec 31, 2025 | -95,000.00 |
| Dec 31, 2025 | -95,000.00 |
| Sep 30, 2025 | -96,000.00 |
| Sep 30, 2025 | -96,000.00 |
| Sep 30, 2025 | -96,000.00 |
| Jun 30, 2025 | -93,000.00 |
| Jun 30, 2025 | -93,000.00 |
| Jun 30, 2025 | -93,000.00 |
| Mar 31, 2025 | -90,000.00 |
| Mar 31, 2025 | -90,000.00 |
| Mar 31, 2025 | -90,000.00 |
| Dec 31, 2024 | -88,000.00 |
| Dec 31, 2024 | -88,000.00 |
| Dec 31, 2024 | -88,000.00 |
| Sep 30, 2024 | -88,000.00 |
| Sep 30, 2024 | -88,000.00 |